$0.862100
-0.04-4.21%
Last update: 7:00 AM
15 minutes delayed
Comments
Loading...
TC BioPharm (Holdings)
TCBPNASDAQ
TC BioPharm (Holdings) (NASDAQ:TCBP) Stock, Analyst Ratings, Price Targets, Forecasts
TC BioPharm (Holdings) PLC has a consensus price target of $6 based on the ratings of 2 analysts. The high is $7 issued by HC Wainwright & Co. on April 27, 2023. The low is $5 issued by EF Hutton on March 28, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and EF Hutton on April 27, 2023, January 26, 2023, and March 28, 2022, respectively. With an average price target of $7 between HC Wainwright & Co., HC Wainwright & Co., and EF Hutton, there's an implied 684.05% upside for TC BioPharm (Holdings) PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
EF Hutton
1calculated from analyst ratings
Analyst Ratings for TC BioPharm (Holdings)
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/27/2023 | Buy Now | 684.05% | HC Wainwright & Co. | Mitchell Kapoor | $1800 → $1400 | Maintains | Buy | Get Alert |
| 01/26/2023 | Buy Now | 908.06% | HC Wainwright & Co. | Mitchell Kapoor | → $1800 | Initiates | → Buy | Get Alert |
| 03/28/2022 | Buy Now | 460.04% | EF Hutton | Constantine Davides | → $50000 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for TC BioPharm (Holdings) (TCBP) stock?
The latest price target for TC BioPharm (Holdings) (NASDAQ:TCBP) was reported by HC Wainwright & Co. on April 27, 2023. The analyst firm set a price target for $7.00 expecting TCBP to rise to within 12 months (a possible 711.97% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for TC BioPharm (Holdings) (TCBP)?
The latest analyst rating for TC BioPharm (Holdings) (NASDAQ:TCBP) was provided by HC Wainwright & Co., and TC BioPharm (Holdings) maintained their buy rating.
When was the last upgrade for TC BioPharm (Holdings) (TCBP)?
There is no last upgrade for TC BioPharm (Holdings)
When was the last downgrade for TC BioPharm (Holdings) (TCBP)?
There is no last downgrade for TC BioPharm (Holdings).
When is the next analyst rating going to be posted or updated for TC BioPharm (Holdings) (TCBP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TC BioPharm (Holdings), and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TC BioPharm (Holdings) was filed on April 27, 2023 so you should expect the next rating to be made available sometime around April 27, 2024.
Is the Analyst Rating TC BioPharm (Holdings) (TCBP) correct?
While ratings are subjective and will change, the latest TC BioPharm (Holdings) (TCBP) rating was a maintained with a price target of $9.00 to $7.00. The current price TC BioPharm (Holdings) (TCBP) is trading at is $0.86, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.